Cargando…

Bridging case-control studies and randomized trials

Randomized trials and observational studies, such as case-control studies, are often seen as opposing approaches. However, in many instances results obtained by different designs may complement each other. For instance, case-control studies on aetiology of disease may help to give the direction of f...

Descripción completa

Detalles Bibliográficos
Autor principal: Rosendaal, Frits R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59634/
https://www.ncbi.nlm.nih.gov/pubmed/11806781
http://dx.doi.org/10.1186/cvm-2-3-109
_version_ 1782120090285637632
author Rosendaal, Frits R
author_facet Rosendaal, Frits R
author_sort Rosendaal, Frits R
collection PubMed
description Randomized trials and observational studies, such as case-control studies, are often seen as opposing approaches. However, in many instances results obtained by different designs may complement each other. For instance, case-control studies on aetiology of disease may help to give the direction of future trials. In this commentary, the author discusses the purpose of randomization and observation, and under which conditions one design may be preferred to another. Randomization is useful to combat 'confounding by indication', and is therefore the design of choice for most therapeutic trials. When this confounding is not an issue, as in studies of genetic risk factors or side-effects, then case-control studies are preferred.
format Text
id pubmed-59634
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-596342001-11-06 Bridging case-control studies and randomized trials Rosendaal, Frits R Curr Control Trials Cardiovasc Med Commentary Randomized trials and observational studies, such as case-control studies, are often seen as opposing approaches. However, in many instances results obtained by different designs may complement each other. For instance, case-control studies on aetiology of disease may help to give the direction of future trials. In this commentary, the author discusses the purpose of randomization and observation, and under which conditions one design may be preferred to another. Randomization is useful to combat 'confounding by indication', and is therefore the design of choice for most therapeutic trials. When this confounding is not an issue, as in studies of genetic risk factors or side-effects, then case-control studies are preferred. BioMed Central 2001 2001-05-31 /pmc/articles/PMC59634/ /pubmed/11806781 http://dx.doi.org/10.1186/cvm-2-3-109 Text en Copyright © 2001 BioMed Central Ltd
spellingShingle Commentary
Rosendaal, Frits R
Bridging case-control studies and randomized trials
title Bridging case-control studies and randomized trials
title_full Bridging case-control studies and randomized trials
title_fullStr Bridging case-control studies and randomized trials
title_full_unstemmed Bridging case-control studies and randomized trials
title_short Bridging case-control studies and randomized trials
title_sort bridging case-control studies and randomized trials
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59634/
https://www.ncbi.nlm.nih.gov/pubmed/11806781
http://dx.doi.org/10.1186/cvm-2-3-109
work_keys_str_mv AT rosendaalfritsr bridgingcasecontrolstudiesandrandomizedtrials